Latest Markets Business BEEPS IPOs Personal Finance

Advent To Buy Suven Pharma In A Rs 9,589-Crore Deal

NDTV Profit
Global private equity firm Advent International will acquire a 50.1% stake in Suven Pharma, buying 12.75 crore shares for a total of Rs 6,313 crore. Suven Pharma MD Venkateswarlu Jasti discusses the acquisition.
Add us to your Preferences
Set as your preferred source on Google

RECOMMENDED FOR YOU

Rs 1,100 Crore Deal: Nehru's Historic Delhi Home Becomes One of India's Costliest
timelogo Sep 04, 2025
IndiGo Share Price Falls After Promoter Offloads Equity Via Block Deal
timelogo Aug 28, 2025
Tariffs On Auto, Pharma Capped At 15% — US, EU Lock In Trade Deal
timelogo Aug 21, 2025
Suven Life Sciences Eyes 2027 Breakthrough For Alzheimer’s Drug, Targets Multibillion-Dollar Opportunity
timelogo Aug 20, 2025